Dai Han Pharmaceutical Co (XKRX:023910) Accounts Payable & Accrued Expense : ₩34,622 Mil (As of Jun. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Dai Han Pharmaceutical Co Accounts Payable & Accrued Expense?

Dai Han Pharmaceutical Co's quarterly accounts payable & accrued expense increased from Dec. 2023 (₩36,577 Mil) to Mar. 2024 (₩38,541 Mil) but then declined from Mar. 2024 (₩38,541 Mil) to Jun. 2024 (₩34,622 Mil).

Dai Han Pharmaceutical Co's annual accounts payable & accrued expense increased from Dec. 2021 (₩31,009 Mil) to Dec. 2022 (₩35,005 Mil) and increased from Dec. 2022 (₩35,005 Mil) to Dec. 2023 (₩36,577 Mil).

Dai Han Pharmaceutical Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Dai Han Pharmaceutical Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dai Han Pharmaceutical Co Accounts Payable & Accrued Expense Chart

Dai Han Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

30,132.71

26,583.78

31,009.19

35,004.80

36,576.89

Dai Han Pharmaceutical Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															31,143.21	32,460.26	36,576.89	38,540.77	34,622.22

Dai Han Pharmaceutical Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Dai Han Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dai Han Pharmaceutical Co Ltd (XKRX:023910) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

8-3, 4-Ga Yangpyeong-dong, Yeongdeungpo-gu, Seoul, KOR

Website

http://www.daihan.com

Dai Han Pharmaceutical Co Ltd is a South Korea based company engages in the manufacture, supply, and distribution of pharmaceutical products such as infusions, injections, drugs used in contrast media, drugs used for external uses and quasi-drugs.

Dai Han Pharmaceutical Co Headlines

No Headlines